Sonnet BioTherapeutics (SONN) Return on Assets (ROA) (2011 - 2025)
Sonnet BioTherapeutics (SONN) Return on Assets (ROA) from Jun 30, 2011 to Sep 30, 2025. The TTM Sonnet BioTherapeutics (SONN) Return on Assets (ROA) is -37.51%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROA
Quarterly ROA
Annual Return on Assets (ROA) change of Sonnet BioTherapeutics (SONN)
| Year | Return on Assets (ROA) | Change |
|---|---|---|
| 2025 | -107.59% | -59.94% |
| 2024 | -268.59% | -22.55% |
| 2023 | -346.78% | -31.97% |
| 2022 | -509.78% | +491.61% |
| 2021 | -86.17% | -71.63% |
| 2020 | -303.75% | +440.18% |
| 2019 | -56.23% | -99.54% |
| 2019 | -12175.00% | +52847.92% |
| 2018 | -22.99% | -100.00% |
| 2018 | -Infinity% | +Infinity% |
| 2017 | -22.50% | -17.02% |
| 2016 | -27.11% | -5.73% |
| 2015 | -28.76% | +60.84% |
| 2014 | -17.88% | -31.05% |
| 2013 | -25.93% | -37.42% |
| 2012 | -41.44% | +71.47% |
| 2011 | -24.17% | N/A |
| 2011 | -24.17% | -66.26% |
| 2010 | -71.63% | N/A |
| 2010 | -71.63% | N/A |